|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-6-25
|
|
pubmed:abstractText |
A new medical approach to primary biliary cirrhosis (PBC) has been desired. We investigated the feasibility of using combination ursodeoxycholic acid (UDCA)-bezafibrate therapy in patients with PBC nonresponsive to UDCA monotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0944-1174
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
573-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12825134-Alkaline Phosphatase,
pubmed-meshheading:12825134-Bezafibrate,
pubmed-meshheading:12825134-Bile Acids and Salts,
pubmed-meshheading:12825134-Cholagogues and Choleretics,
pubmed-meshheading:12825134-Drug Administration Schedule,
pubmed-meshheading:12825134-Drug Therapy, Combination,
pubmed-meshheading:12825134-Female,
pubmed-meshheading:12825134-Humans,
pubmed-meshheading:12825134-Hypolipidemic Agents,
pubmed-meshheading:12825134-Liver Cirrhosis, Biliary,
pubmed-meshheading:12825134-Male,
pubmed-meshheading:12825134-Middle Aged,
pubmed-meshheading:12825134-Time Factors,
pubmed-meshheading:12825134-Ursodeoxycholic Acid
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Bezafibrate treatment: a new medical approach for PBC patients?
|
|
pubmed:affiliation |
First Department of Medicine, Chiba University School of Medicine, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
